Concordantly, in nonseminomas, there was a highly significant correlation between gain of 3p25.3 and shorter PFS (Fig 3 C) while no such association was found in seminomas (Data Supplement).
← all excerpts
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors.
1
—
—